Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-30
2007-10-30
Berch, Mark (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S238000, C544S239000, C544S232000, C514S850000, C514S252030, C514S252050
Reexamination Certificate
active
11085869
ABSTRACT:
The present invention relates to a compounds according to formula I, methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula I and pharmaceutical compositions for treating diseases mediated by human immunodeficieny virus containing a compound according to formula I where R1, R2, R3, R4, R5, R6, R7and R8are as defined herein
REFERENCES:
patent: 5886178 (1999-03-01), Allen et al.
patent: 2004/0198736 (2004-10-01), Dunn et al.
patent: WO96/24343 (1996-08-01), None
patent: WO96/34851 (1996-11-01), None
patent: WO97/02023 (1997-01-01), None
patent: WO97/02024 (1997-01-01), None
patent: WO 01/86570 (2001-11-01), None
West, Solid State Chemistry, 1988, pp. 358, 365.
Vippagunta, et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
Ulrich, Kirk-Othmer Encyclopedia of Chemical Technology, 2002.
Moore, et al., Biochem. J. (1992) 288, 717-719.
Marcus, et al., PubMed Abstract, 2002.
van Heeswijk, et al., PubMed Abstract, 2001.
, Miles, Medline abstract, 2005.
Webster's Comprehensive Dictionary, 1996.
De Clercq, Erik, “New Developments in Anti-HIV Chemotherapy,”Current Medicinal Chemistry, 2001, pp. 1543-1572, vol. 8. No. 13.
Leeson, Paul D., “Selective Thyromimetics. Cardiac-Sparing Thyroid Hormone Analogues Containing 3′-Arylmethyl Substituents,”J. Med. Chem., 1989, pp. 320-336, vol. 32, No. 2.
H. Bundgaar,Design of Prodrugs: Bioreversible derivatives for various functional groups and chemical entities in Design of Prodrugs, H. Bundgaard (ed) Elsevier Science Publishers, Amersterdam 1985, pp. 10-27.
S. A. Varia et al., “Phenytoin Prodrugs III: Water soluble prodrugs for Oral and/or Parental Use,”J. Pharm. Sci., 1984 pp. 1068-1073, vol. 73:8.
Buckheit, Jr., Robert W., “Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection,”Expert Opin. Investig. Drugs, Ashley Publications Ltd., 2001, pp. 1423-1442, vol. 10, No. 8.
Dunn James Patrick
Elworthy Todd Richard
Hogg Joan Heather
Stefanidis Dimitrios
Berch Mark
Buckwalter Brian L.
Jaisle Cecilia
Roche Palo Alto LLC
LandOfFree
Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3868697